Jessica K Holien (Jessica Holien)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 11

Top Venues

NAR genomics and bioinformatics

Cancers

Current oncology reports

Mycoses

This page only lists publications with an associated author ORCID identifier.

Publications

Olivia Craig, Samuel Lee, Courtney Pilcher, Rita Saoud, Suad Abdirahman, Carolina Salazar, Nathan Williams, David Benjamin Ascher, Robert Vary, Jennii Luu, Karla J Cowley, Susanne Ramm, Mark Xiang Li, Niko Thio, Jason Li, Tim Semple, Kaylene J Simpson, Kylie L Gorringe, Jessica K Holien
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma. NAR genomics and bioinformatics 6 (3) (2024)
Olivia Craig, Samuel Lee, Courtney Pilcher, Rita Saoud, Suad Abdirahman, Carolina Salazar, Nathan Williams, David Benjamin Ascher, Robert Vary, Jennii Luu, Karla J Cowley, Susanne Ramm, Mark Xiang Li, Niko Thio, Jason Li, Tim Semple, Kaylene J Simpson, Kylie L Gorringe, Jessica K Holien
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma. NAR genomics and bioinformatics 6 (3) (2024)
Phemelo Mechidi, Jessica K Holien, Danilla Grando, Tien T Huynh, Ann C Lawrie
New Sources of Resistance to Terbinafine Revealed and Squalene Epoxidase Modelled in the Dermatophyte Fungus Trichophyton interdigitale From Australia. Mycoses 67 (9) (2024)
Hassina Massudi, Jie-Si Luo, Jessica K Holien, Satyanarayana Gadde, Sukriti Krishan, Mika Herath, Jessica Koach, Brendan W Stevenson, Michael A Gorman, Pooja Venkat, Chelsea Mayoh, Xue-Qun Luo, Michael W Parker, Belamy B Cheung, Glenn M Marshall
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface. Cancers 15 (6) (2023)
Hassina Massudi, Jie-Si Luo, Jessica K Holien, Satyanarayana Gadde, Sukriti Krishan, Mika Herath, Jessica Koach, Brendan W Stevenson, Michael A Gorman, Pooja Venkat, Chelsea Mayoh, Xue-Qun Luo, Michael W Parker, Belamy B Cheung, Glenn M Marshall
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein Interface. Cancers 15 (6) (2023)
Aram Niaz, Jia Quyen Truong, Annabel Manoleras, Lucy Claire Fox, Piers Blombery, Raja S Vasireddy, Hilda A Pickett, Julie A Curtin, Pasquale M Barbaro, Jonathan Rodgers, John Roy, Lisa G Riley, Jessica K Holien, Scott B Cohen, Tracy M Bryan
Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder. Blood advances 6 (12) (2022)
Yali Deng, Doan T M Ngo, Jessica K Holien, Jarmon G Lees, Shiang Y Lim
Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology. Current oncology reports 24 (12) (2022)
Jia Quyen Truong, Ashwin George, Jessica K Holien
Analysis of physicochemical properties of protein-protein interaction modulators suggests stronger alignment with the "rule of five". RSC medicinal chemistry 12 (10) (2021)
Jessica L Bell, Sven Hagemann, Jessica K Holien, Tao Liu, Zsuzsanna Nagy, Johannes H Schulte, Danny Misiak, Stefan Hüttelmaier
Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma. International journal of molecular sciences 21 (14) (2020)
Bishnu P Paudel, Aaron Lavel Moye, Hala Abou Assi, Roberto El-Khoury, Scott B Cohen, Jessica K Holien, Monica L Birrento, Siritron Samosorn, Kamthorn Intharapichai, Christopher G Tomlinson, Marie-Paule Teulade-Fichou, Carlos González, Jennifer L Beck, Masad J Damha, Antoine M van Oijen, Tracy M Bryan
A mechanism for the extension and unfolding of parallel telomeric G-quadruplexes by human telomerase at single-molecule resolution. eLife 9 (2020)
Ueli Nachbur, Che A Stafford, Aleksandra Bankovacki, Yifan Zhan, Lisa M Lindqvist, Berthe K Fiil, Yelena Khakham, Hyun-Ja Ko, Jarrod J Sandow, Hendrik Falk, Jessica K Holien, Diep Chau, Joanne Hildebrand, James E Vince, Phillip P Sharp, Andrew I Webb, Katherine A Jackman, Sabrina Mühlen, Catherine L Kennedy, Kym N Lowes, James M Murphy, Mads Gyrd-Hansen, Michael W Parker, Elizabeth L Hartland, Andrew M Lew, David C S Huang, Guillaume Lessene, John Silke
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production. Nature communications 6 (2015)

Jessica K Holien.css-eqlu8i{font-size:small;padding-left:4px;} (Jessica Holien)

Publication Activity (10 Years)

Top Topics

Top Venues

Jessica K Holien (Jessica Holien)